Novel oxadiazole derivatives as potent inhibitors of α-amylase and α-glucosidase enzymes: Synthesis, in vitro evaluation, and molecular docking studies
Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 142
This Paper With 11 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJBMS-24-12_003
تاریخ نمایه سازی: 20 آذر 1400
Abstract:
Objective(s): Alpha-amylase and alpha-glucosidase enzyme inhibition is an effective and rational approach for controlling postprandial hyperglycemia in type II diabetes mellitus (DM). Several inhibitors of this therapeutic class are in clinical use but are facing challenges of safety, efficacy, and potency. Keeping in view the importance of these therapeutic inhibitors, in this study we are reporting ۱۰ new oxadiazole analogs ۵ (a-g) & ۴a (a-c) as antidiabetic agents. Materials and Methods: The newly synthesized derivatives ۵ (a-g) & ۴a (a-c) were characterized using different spectroscopic techniques including FTIR,۱HNMR, ۱۳CNMR, and elemental analysis data. All compounds were screened for their in vitro α-amylase and α-glucosidase enzyme inhibitory potential, while two selected compounds (۵a and ۵g) were screened for cytotoxicity using MTT assay.Results: Two analogues ۵a and ۴a (a) exhibited strong inhibitory potential against α-glucosidase enzyme, i.e., IC۵۰ value=۱۲.۲۷±۰.۴۱ µg/ml and ۱۵.۴۵±۰.۲۰ µg/ml, respectively in comparison with standard drug miglitol (IC۵۰ value=۱۱.۴۷±۰.۰۲ µg/ml) whereas, one compound ۵g demonstrated outstanding inhibitory potential (IC۵۰ value=۱۳.۰۹±۰.۰۶ µg/ml) against α-amylase enzyme in comparison with standard drug acarbose (IC۵۰ value=۱۲.۲۰±۰.۷۸ µg/ml). The molecular interactions of these active compounds in the enzymes’ active sites were evaluated following molecular docking studies. Conclusion: Our results suggested that these new oxadiazole derivatives (۵a, ۵g & ۴a (a)) may act as promising drug candidates for the development of new alpha-amylase and alpha-glucosidase inhibitors. Therefore, we further recommend in vitro and in vivo pharmacological evaluations and safety assessments.
Keywords:
Authors
Asma Bukhari
Riphah Institute of Pharmaceutical Sciences, Riphah International University Islamabad, ۴۴۰۰۰, Pakistan
Humaira Nadeem
Riphah Institute of Pharmaceutical Sciences, Riphah International University Islamabad, ۴۴۰۰۰, Pakistan
Muhammad Imran
Department of Pharmacy, Iqra University H-۹ Campus Islamabad, ۴۴۰۰۰, Pakistan
Syed Aun Muhammad
Department of Biotechnology, Bahauddin Zakariya University (BZU), Multan, Pakistan
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :